BC.GAME Launches Exclusive Airdrop for Polymarket Users, Rewarding Participation in U.S. Election Prediction Markets
WILLEMSTAD, Curacao, Nov. 7, 2024 /PRNewswire/ — Following the frenzy surrounding the 2024 U.S. presidential election, global leading crypto igaming platform... Read more.
Ecobank Partners with Nium to Unlock Real-Time Cross-Border Payments Across 35 African Markets
Nium announces its partnership with Ecobank, a pan-African financial solutions leader, bringing real-time cross-border payments to 35 markets on the continent SINGAPORE,... Read more.
BLUETTI and UN-Habitat Forge Partnership to Promote Clean Energy and Sustainable Development Across Africa
CAIRO, Nov. 7, 2024 /PRNewswire/ — BLUETTI, a global leader in clean energy storage solutions, has entered into a strategic partnership with the United Nations... Read more.
WuXi XDC Named Best CDMO Winner at 2024 World ADC Awards
SHANGHAI and SAN DIEGO, Nov. 7, 2024 /PRNewswire/ — WuXi XDC Cayman Inc. (“WuXi XDC” or the “Company”, stock code: 2268.HK), a leading... Read more.
Global Times: GT survey shows nearly 90 percent of Americans concerned about China-US ties
BEIJING, Nov. 7, 2024 /PRNewswire/ — As the most closely watched event in the “super election year,” the 2024 US presidential election is likely... Read more.
Saramonic Ultra Launched: A Pro Wireless Microphone with Timecode for Pro Creators
NEW YORK, Nov. 7, 2024 /PRNewswire/ — Saramonic launches its latest wireless lavalier microphone—Saramonic Ultra—for professional creators. With timecode,... Read more.
Aulisa® Medical Expands Access with New Leasing Options for Procuring Advanced Monitoring Solutions
PALO ALTO, Calif., Nov. 7, 2024 /PRNewswire/ — Aulisa® Medical USA, Inc., a leader in FDA-cleared, wearable, wireless continuous vital sign monitoring technology,... Read more.
InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC
NANJING, China, Nov. 7, 2024 /PRNewswire/ — InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against tumor-treatment... Read more.
JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio’s Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma
—— The Phase 1b/2 study FUMANBA-1 demonstrates Equecabtagene Autoleucel led to deep and durable responses in patients with R/RMM —— The data shows the overall... Read more.
Shanghai thriving as global investment hub
BEIJING, Nov. 7, 2024 /PRNewswire/ — A news report from chinadaily.com.cn： The 2024 Shanghai City Investment Promotion Conference, held on Nov 6, serves... Read more.